Skip to main content

Advertisement

Log in

Canada population norms for the EQ-5D-5L

  • Original Paper
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

Abstract

Objective

In Canada, population norms are only available for 2 provinces, Alberta and Quebec. The objective of this study was to derive the population norms for the EQ-5D-5L based on a representative sample of the Canadian general population.

Methods

Data from the Canadian EQ-5D-5L valuation study, a cross-sectional study, were used. A quota sampling method was used to recruit a representative sample of the Canadian general population in terms of age, sex, and education. EQ-5D-5L utilities and EQ VAS were summarized using descriptive statistics and the impact of demographic characteristics on the EQ-5D-5L utilities was evaluated using statistical hypothesis testing and Tobit regression.

Results

1207 eligible participants were included in the analysis. Pain/discomfort (53.1%) was the most frequently reported domain with any problem, and self-care (7.6%) domain was the least. The mean (standard deviation [SD]) EQ-5D-5L utility was 0.864 (0.121) and the mean (SD) EQ VAS was 82.3 (14.23). The highest mean EQ-5D-5L utility was 0.881 in age group 25–34 while the lowest was 0.839 in age group 55–64. Participants who had full-time employment, were married, a higher annual household income and no chronic health conditions had significantly higher EQ-5D-5L utilities.

Conclusion

This article reports the first Canadian population norms for the EQ-5D-5L and can be used as population references for economic evaluations and clinical research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Availability of data and material

Not applicable.

References

  1. Taylor, V.R., Measuring healthy days; population assessment of health-related quality of life (2000)

  2. Stolk, E., et al.: Overview, update, and lessons learned from the international EQ-5D-5L valuation work: version 2 of the EQ-5D-5L valuation protocol. Value Health 22(1), 23–30 (2019)

    Article  PubMed  Google Scholar 

  3. Ramos-Goni, J.M., et al.: Quality control process for EQ-5D-5L valuation studies. Value Health 20(3), 466–473 (2017)

    Article  PubMed  Google Scholar 

  4. van Hout, B., et al.: Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 15(5), 708–715 (2012)

    Article  PubMed  Google Scholar 

  5. Group, E. EQ-5D Available from: https://euroqol.org/.

  6. Herdman, M., et al.: Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20(10), 1727–1736 (2011)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kennedy-Martin, M., et al.: Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. Eur J Health Econ 21(8), 1245–1257 (2020)

    Article  PubMed  PubMed Central  Google Scholar 

  8. Xie, F., Eleanor, P., Gaebel, K., Bansback, N., Bryan, S., Ohinmaa, A., Poissant, L., Johnson, J.A.: A time trade-off-derived value set of the EQ-5D-5L for Canada. Med. Care 54(1), 98–105 (2016)

    Article  PubMed  Google Scholar 

  9. Bess, S., et al.: The Health impact of symptomatic adult spinal deformity: comparison of deformity types to United States Population Norms and Chronic Diseases. Spine (Phila Pa 1976) 41(3), 224–233 (2016)

    Article  PubMed  Google Scholar 

  10. Sutherland, H.J., Fyles, G.M., Adams, G., Hao, Y., Lipton, J.H., Minden, M.D., Meharchand, J.M., Tejpar, I., Messner, H.A., Atkins, H.: Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transpl 19, 1129–1136 (1997)

    Article  CAS  Google Scholar 

  11. Raznahan, A., et al.: Compared to what? Early brain overgrowth in autism and the perils of population norms. Biol Psychiatry 74(8), 563–575 (2013)

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hawkins, K.A., Bender, S.: Norms and the relationship of Boston naming test performance to vocabulary and education: a review. Aphasiology 16(12), 1143–1153 (2002)

    Article  Google Scholar 

  13. Team, T.A., Alberta Population Norms for EQ-5D-5L: Alberta PROMs & EQ-5D Research & Support Unit (APERSU). School of Public Health, University of Alberta (2018)

    Google Scholar 

  14. Poder, T.G., Carrier, N., Kouakou, C.R.C.: Quebec health-related quality-of-life population norms using the EQ-5D-5L: decomposition by sociodemographic data and health problems. Value Health 23(2), 251–259 (2020)

    Article  PubMed  Google Scholar 

  15. Azzi, J., et al.: PNS261 EQ-5D-5L in France, Germany and Spain: Population Norms and Comparison between the Countries. Value in Health 23, S685 (2020)

    Article  Google Scholar 

  16. Bailey, H., et al.: EQ-5D self-reported health in Barbados and Jamaica with EQ-5D-5L population norms for the English-speaking Caribbean. Health Qual. Life Outcomes 19(1), 97 (2021)

    Article  PubMed  PubMed Central  Google Scholar 

  17. Bailey, H., et al.: Health-related quality of life population norms for Belize using EQ-5D-5L. Value Health Reg. Issues 29, 45–52 (2022)

    Article  PubMed  Google Scholar 

  18. Bailey, H., et al.: EQ-5D-5L population norms and health inequalities for Trinidad and Tobago. PLoS ONE 14(4), e0214283 (2019)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Cesana, L.S.P.A.C.R.C.G. and L.G. Mantovani, health related quality of life norm data of the general population in Italy: results using the EQ-5D-3L and EQ-5D-5L instruments. Epidemiology Biostatistics and Public Health 12(3), (2015

  20. Emrani, Z., et al.: Health-related quality of life measured using the EQ-5D-5 L: population norms for the capital of Iran. Health Qual. Life Outcomes 18(1), 108 (2020)

    Article  PubMed  PubMed Central  Google Scholar 

  21. Encheva, M., et al.: EQ-5D-5L Bulgarian population norms. Eur. J. Health Econ 21(8), 1169–1178 (2020)

    Article  PubMed  Google Scholar 

  22. Garcia-Gordillo, M.A., Adsuar, J.C., Olivares, P.R.: Normative values of EQ-5D-5L: in a Spanish representative population sample from Spanish Health Survey, 2011. Qual Life Res 25(5), 1313–1321 (2016)

    Article  CAS  PubMed  Google Scholar 

  23. Garratt, A.M., et al.: Norwegian population norms for the EQ-5D-5L: results from a general population survey. Qual Life Res 31(2), 517–526 (2022)

    Article  PubMed  Google Scholar 

  24. Golicki, D., Niewada, M.: EQ-5D-5L Polish population norms. Arch Med Sci 13(1), 191–200 (2017)

    Article  PubMed  Google Scholar 

  25. Hernandez, G., et al.: Validity of the EQ-5D-5L and reference norms for the Spanish population. Qual Life Res 27(9), 2337–2348 (2018)

    Article  PubMed  Google Scholar 

  26. Hobbins, A., et al.: The health of the residents of Ireland: Population norms for Ireland based on the EQ-5D-5L descriptive system - a cross sectional study. HRB Open Res 1, 22 (2018)

    Article  PubMed  PubMed Central  Google Scholar 

  27. Jensen, M.B., et al.: Danish population health measured by the EQ-5D-5L. Scand J Public Health (2021). https://doi.org/10.1177/14034948211058060

    Article  PubMed  PubMed Central  Google Scholar 

  28. Jiang, R., Janssen, M.F.B., Pickard, A.S.: US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples. Qual Life Res 30(3), 803–816 (2021)

    Article  PubMed  Google Scholar 

  29. Marten, O., Greiner, W.: EQ-5D-5L reference values for the German general elderly population. Health Qual. Life Outcomes 19(1), 76 (2021)

    Article  PubMed  PubMed Central  Google Scholar 

  30. McCaffrey, N., et al.: Health-related quality of life measured using the EQ-5D-5L: South Australian population norms. Health Qual. Life Outcomes 14(1), 133 (2016)

    Article  PubMed  PubMed Central  Google Scholar 

  31. Nguyen, L.H., et al.: Quality of life profile of general Vietnamese population using EQ-5D-5L. Health Qual. Life Outcomes 15(1), 199 (2017)

    Article  PubMed  PubMed Central  Google Scholar 

  32. Prevolnik Rupel, V., Ogorevc, M.: EQ-5D-5L Slovenian population norms. Health Qual. Life Outcomes 18(1), 333 (2020)

    Article  PubMed  PubMed Central  Google Scholar 

  33. Purba, F.D., et al.: Quality of life of the Indonesian general population: Test-retest reliability and population norms of the EQ-5D-5L and WHOQOL-BREF. PLoS ONE 13(5), e0197098 (2018)

    Article  PubMed  PubMed Central  Google Scholar 

  34. Shiroiwa, T., et al.: Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual. Life Res 25(3), 707–719 (2016)

    Article  PubMed  Google Scholar 

  35. Sullivan, T., et al.: New Zealand population norms for the EQ-5D-5L constructed from the personal value sets of participants in a national survey. Value Health 24(9), 1308–1318 (2021)

    Article  PubMed  Google Scholar 

  36. Van Wilder, L., et al.: Belgian population norms for the EQ-5D-5L, 2018. Qual. Life Res 31(2), 527–537 (2022)

    Article  PubMed  Google Scholar 

  37. Wong, E.L., et al.: Normative profile of health-related quality of life for Hong Kong general population using preference-based instrument EQ-5D-5L. Value Health 22(8), 916–924 (2019)

    Article  PubMed  Google Scholar 

  38. Xie, S., Wu, J., Xie, F.: Population Norms for SF-6Dv2 and EQ-5D-5L in China. Appl Health Econ Health Policy 20, 573–585 (2022)

    Article  PubMed  Google Scholar 

  39. Yang, Z., et al.: EQ-5D-5L norms for the urban Chinese population in China. Health Qual. Life Outcomes 16(1), 210 (2018)

    Article  PubMed  PubMed Central  Google Scholar 

  40. Bailey, H.H., et al.: EQ-5D-5L population norms and health inequality in Colombia. Value Health Reg Issues 26, 24–32 (2021)

    Article  PubMed  Google Scholar 

  41. Oppe, M., et al.: A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value Health 17(4), 445–453 (2014)

    Article  PubMed  Google Scholar 

  42. R Core Team R: A language and environment for statistical computing. Foundation for Statistical Computing, Vienna, Austria (2022)

  43. Yee, T.W., Hadi, A.F.: Row-column interaction models, with an R implementation. Comput. Stat. 29(6), 1427–1445 (2014)

    Article  Google Scholar 

  44. Yee, T.W., Stoklisa, J., Huggins, R.M.: The VGAM package for capture-recapture data using the conditional likelihood. J. Stat. Softw. 65(5), 1–33 (2015)

    Article  Google Scholar 

  45. Yee, T.W., Wild, C.J.: Vector generalized additive models. J. R. Stat. Soc. Ser. B 58(3), 481–493 (1996)

    Google Scholar 

  46. Yee, T.W.: Vector generalized linear and additive models: with an implementation in R. Springer, New york (2015)

    Book  Google Scholar 

  47. Yee, T.W.: The VGAM package for categorical data analysis. J. Stat. Softw. 32(10), 1–34 (2010)

    Article  Google Scholar 

  48. Yee, T.W.: VGAM: vector generalized linear and additive models R package version 1.0–5 (2018)

  49. Yee, T.W.: Two-parameter reduced-rank vector generalized linear models. Comput. Stat. Data Anal. 71, 889–902 (2013)

    Article  Google Scholar 

  50. Son, C.-H.: The effects of retirement on health-related quality of life of retirement-aged adults for four marital status subgroups. Int. J. Econ. Sci. (2020). https://doi.org/10.20472/ES.2020.9.1.010

    Article  Google Scholar 

  51. Holownia-Voloskova, M., Tarbastaev, A., Golicki, D.: Population norms of health-related quality of life in Moscow, Russia: the EQ-5D-5L-based survey. Qual. Life Res. 30(3), 831–840 (2021)

    Article  PubMed  Google Scholar 

  52. Pickard, A.S., Neary, M.P., Cella, D.: Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual. Life Outcomes 5, 70 (2007)

    Article  PubMed  PubMed Central  Google Scholar 

  53. Tsai, A.P.Y., et al.: Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease. Thorax 76(1), 37–43 (2021)

    Article  PubMed  Google Scholar 

Download references

Funding

The original Canadian EQ-5D-5L valuation study was funded by the Canadian Institutes of Health Research. No funding was received for the development of the Canadian norms.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Feng Xie.

Ethics declarations

Ethical approval

This study was a secondary data analysis, and no data were collected for this analysis. Ethical approval was not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 432 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yan, J., Xie, S., Johnson, J.A. et al. Canada population norms for the EQ-5D-5L. Eur J Health Econ 25, 147–155 (2024). https://doi.org/10.1007/s10198-023-01570-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-023-01570-1

Keywords

Navigation